期刊
TOXIN REVIEWS
卷 39, 期 1, 页码 52-56出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15569543.2018.1477162
关键词
Daboia (Vipera) palaestinae; snake bite; envenomation; antivenom; fixed dose
类别
Background: Daboia (Vipera) palaestinae envenomation (DPE) is the most common snake-bite in Israel. Current practice has supported antivenom treatment, including those with local or systemic manifestations. Objective: To evaluate a conservative approach vs. fixed dose D. palaestinae antivenom for patients with advance local (AL)/mild systemic (MS) manifestations. Methods: Retrospective analysis of 41 patients bitten by D. palaestinae who were treated with expectant management or administration of a fixed-dose of 50 mL antivenom. Results: Antivenom was withheld in 16/21 patients (76%) with AL or MS reaction. After expectant management, no adverse events were recorded. Conclusion: We found that a selective approach towards antivenom administration yields similar clinical outcomes in patients following DPE.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据